Discontinuation of first-line molecular-targeted therapy...

  • Main
  • 2020 / 7
  • Discontinuation of first-line molecular-targeted therapy...
Urologic Oncology: Seminars and Original Investigations 2020 / 7

Discontinuation of first-line molecular-targeted therapy and prognosis in patients with metastatic renal cell carcinoma: Impact of disease progression vs. adverse events

Ando, Ryosuke, Takahara, Kiyoshi, Ito, Toshiki, Kanao, Kent, Kobayashi, Ikuo, Shiroki, Ryoichi, Sumitomo, Makoto, Miyake, Hideaki, Yasui, Takahiro
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Journal:
Urologic Oncology: Seminars and Original Investigations
DOI:
10.1016/j.urolonc.2020.06.023
Date:
July, 2020
File:
PDF, 605 KB
2020
Conversion to is in progress
Conversion to is failed